News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lurker Nancy
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2023 |
4
| Lurker Nancy (Executive Vice Chair) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 33,334 restricted stock units
@ $0
Granted 66,666 options to buy
@ $9.11, valued at
$607.3k
|
|
| 05/15/2023 |
4
| Lurker Nancy (CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Gifted 21,250 options to buy
@ $36.3, valued at
$771.4k
Gifted 21,250 options to buy
@ $36.3, valued at
$771.4k
Gifted 65,868 options to buy
@ $26.5, valued at
$1.7M
Gifted 65,868 options to buy
@ $26.5, valued at
$1.7M
Gifted 36,000 options to buy
@ $20.4, valued at
$734.4k
Gifted 36,000 options to buy
@ $20.4, valued at
$734.4k
Gifted 8,000 options to buy
@ $17.7, valued at
$141.6k
Gifted 8,000 options to buy
@ $17.7, valued at
$141.6k
Gifted 120,206 options to buy
@ $13.13, valued at
$1.6M
Gifted 120,206 options to buy
@ $13.13, valued at
$1.6M
Gifted 59,220 options to buy
@ $12.9, valued at
$763.9k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Lurker Nancy (CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 450,800 options to buy
@ $3.26, valued at
$1.5M
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 13,717 restricted stock units
@ $0 |
|
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $20.148, valued at
$201.5k
|
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Lurker Nancy (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.04, valued at
$80.8k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Lurker Nancy (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 14,000 options to buy
@ $5.3, valued at
$74.2k
|
|
| 06/16/2020 |
4
| Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 45,000 restricted stock units
@ $0 |
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
4
| Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 10,745 shares
@ $2.105, valued at
$22.6k
|
|
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 45,000 restricted stock units
@ $0 |
|
| 06/17/2019 |
4
| Lurker Nancy (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 13,350 options to buy
@ $4.38, valued at
$58.5k
|
|
| 04/01/2019 |
4
| Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Bought 28,500 shares
@ $1.763, valued at
$50.2k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2018 |
4
| Lurker Nancy (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 26,700 options to buy
@ $15, valued at
$400.5k
|
|
| 07/24/2018 |
3
| Lurker Nancy (Director) has filed a Form 3 on Aquestive Therapeutics, Inc. |
| 06/29/2018 |
4
| Lurker Nancy (President & CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 40,000 restricted stock units
@ $0 |
|
| 06/18/2018 |
4
| Lurker Nancy (President and CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 135,000 restricted stock units
@ $0
Granted 540,000 options to buy
@ $2.04, valued at
$1.1M
|
|
| 03/21/2018 |
4
| Lurker Nancy (President & CEO) has filed a Form 4 on pSivida Corp.|
Txns:
| Granted 38,333 shares
@ $0 |
|
| 12/19/2017 |
4
| Lurker Nancy (President and CEO) has filed a Form 4 on pSivida Corp.|
Txns:
| Granted 120,000 restricted stock units
@ $0
Granted 240,000 options to buy
@ $1.77, valued at
$424.8k
|
|
|
|
|